drugset / Trial / NCT04531163

Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy

NCT04531163

Phase 2/3 Unknown 60 enrolled Al-Azhar University
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is focused on the possible improving effect of N-acetylcysteine on nephropathy of type-2 diabetic patients. Study design: Prospective clinical based study. The aim of this work is to study the effect of N-acetylcysteine (NAC) on proteinuria and on the serum level of lipoprotein a (LPa) in diabetes induced nephropathy in type-2 diabetic patients.

Timeline

Start
2019-10-01
Primary completion
2020-11-01
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 1200 mg